Saturday, March 7, 2026
HomeHealthSTAT+: The FDA questions underlying Utah’s AI prescription pilot

STAT+: The FDA questions underlying Utah’s AI prescription pilot

Brittany Trang, CEO of Doctronic, recently sat down with STAT’s Mario Aguilar to discuss the company’s groundbreaking pilot program in Utah and the challenges facing AI doctors in today’s healthcare landscape. The conversation, which took place at the AI Prognosis conference, shed light on the potential of AI in improving patient care and the need for continued innovation in the field.

Doctronic, a leading AI healthcare company, has been making waves in the industry with its cutting-edge technology that aims to revolutionize the way doctors diagnose and treat patients. The company’s latest project, a pilot program in Utah, has been garnering attention for its use of AI in assisting doctors in making accurate and timely diagnoses.

During the interview, Trang expressed her excitement about the Utah pilot program and its potential impact on healthcare. She explained that the program uses advanced AI algorithms to analyze patient data and assist doctors in making diagnoses. This not only saves time but also improves the accuracy of diagnoses, ultimately leading to better patient outcomes.

Trang also highlighted the importance of collaboration between AI and human doctors. She emphasized that AI is not meant to replace doctors but rather to work alongside them, providing valuable insights and support. This collaboration, she believes, will lead to a more efficient and effective healthcare system.

However, Trang also acknowledged the challenges facing AI doctors in today’s healthcare landscape. One of the main issues is the lack of data. In order for AI to make accurate and reliable diagnoses, it needs access to a large amount of patient data. This can be a challenge in areas where data collection is not standardized or where patient information is not easily accessible.

Another challenge is the fear of AI replacing human doctors. Trang assured that this is not the case and that AI is simply a tool to assist doctors in their work. She also pointed out the need for proper training and education for doctors to effectively use AI in their practice.

The conversation then shifted to the ethical concerns surrounding AI in healthcare. Trang stressed the importance of transparency and accountability in the development and use of AI. She also mentioned the need for regulations to ensure that AI is used ethically and responsibly in the medical field.

As the interview concluded, Trang expressed her optimism for the future of AI in healthcare. She believes that with continued innovation and collaboration, AI has the potential to greatly improve patient care and revolutionize the healthcare industry.

The Doctronic Utah pilot program is just one example of the advancements being made in the field of AI in healthcare. With the support and collaboration of doctors, researchers, and policymakers, the potential for AI to transform healthcare is endless.

The AI Prognosis conference, where Trang and Aguilar’s conversation took place, serves as a platform for experts to come together and discuss the latest developments and challenges in the field of AI in healthcare. It is through events like these that progress and innovation can be fostered.

In conclusion, the conversation between Brittany Trang and Mario Aguilar shed light on the potential of AI in healthcare and the need for continued collaboration and innovation in the field. With the proper support and ethical considerations, AI has the power to greatly improve patient care and pave the way for a more efficient and effective healthcare system. As Trang aptly stated, “The future of healthcare is not AI versus doctors, but AI and doctors working together.”

Related news

Don't miss